
Please try another search
MADRID (Reuters) - Spain will stop using AstraZeneca (NASDAQ:AZN)'s COVID-19 vaccine for at least 15 days, Cadena Ser radio reported on Monday, citing unnamed sources.
Health Minister Carolina Darias was due to provide an update later on Monday, as a growing list of countries stop administering the shot amid concerns of severe adverse effects.
The Health Ministry declined to comment.
France, Germany and Italy on Monday joined Denmark, Norway and several others in halting use of the drug after reports of blood clots in some patients who had received the vaccine.
The top World Health Organization scientist reiterated on Monday that there have been no documented deaths linked to COVID-19 vaccines.
The WHO appealed to countries not to suspend vaccinations against a disease that has caused more than 2.7 million deaths worldwide.
Last week Darias said her administration was monitoring the situation but had only detected light side-effects such as headaches, dizziness and intestinal trouble.
Nevertheless, several Spanish regions decided to stop using the vaccine until more information became available.
Europe's EMA medicines regulator said it would meet on Thursday to analyse the situation and reaffirmed its view that the benefits of the drug outweigh the risks.
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review
Add a Comment
We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:
Enrich the conversation, don’t trash it.
Stay focused and on track. Only post material that’s relevant to the topic being discussed.
Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.
Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.